Should you buy LIC, Trent, Hindalco, Concord Biotech shares today? Here is what brokerages recommend
Here's what Goldman Sachs, Jefferies, Macquarie, JPMorgan, Citi, Morgan Stanley, CLSA, HSBC and Nomura make of stocks such as Hindalco Industries (HINDALCO), Life Insurance Corporation (LIC), Trent, and Concord Biotech (CONCORDBIO)
As Dalal Street enters the May 29 session, brokerages have few stocks on their radar.
Should you buy LIC, Trent, Hindalco, Concord Biotech shares today?
Here's what Goldman Sachs, Jefferies, Macquarie, JPMorgan, Citi, Morgan Stanley, CLSA, HSBC and Nomura make of stocks such as Hindalco Industries (HINDALCO), Life Insurance Corporation (LIC), Trent, and Concord Biotech (CONCORDBIO)
Should you buy Hindalco shares?
CLSA has maintained a 'buy' call on Hindalco Industries (HINDALCO) shares with a target of Rs 770.
Should you buy Trent shares?
Morgan Stanley has maintained an 'equal-weight' rating on the Trent stock with a target of Rs 4,812.
Should you buy LIC shares?
Two brokerages, Goldman Sachs and Macquarie have maintained a 'neutral' rating on the Life Insurance Corporation (LIC) stock with a target of Rs 950 and Rs 850, respectively.
Should you buy Concord Biotech shares?
Jefferies has maintained a 'hold' call on Concord Biotech (CONCORDBIO) shares with a target of Rs 1,410.
Disclaimer: The views/suggestions/recommendations expressed here in this article are solely by investment experts. Zee Business suggests its readers consult their investment advisers before making any financial decision.